SEC 13F Intelligence

Duquesne Family Office LLC / ASND

Duquesne Family Office LLC’s Ascendis Pharma A/S Position

Does Duquesne Family Office LLC own Ascendis Pharma A/S (ASND)? Not currently — the last reported position was 158.7K shares worth $25M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$25M
Q1 2025
Shares
158.7K
% of Portfolio
+0.81%
Quarters Held
3
position exited

Position History ASND

Reported value by quarter
Q3 ’24: $40MQ3 ’24Q4 ’24: $36MQ4 ’24Q1 ’25: $25MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025158.7K$25M+0.81%
Q4 2024265.0K$36M+0.98%
Q3 2024265.0K$40M+1.34%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of ASND.